Physician profile
Scott E Bingham
NPI 1487612214
$1,152.04
in general payments reported to CMS, 2019-2025
14 companies · $29.71 in 2025
The $29.71 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $109 · 2021: $185 · 2022: $162 · 2023: $266 · 2024: $224 · 2025: $29.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $575.51 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $95.58 | 2019-2021 | |
| Pfizer INC. | $82.84 | 2020-2023 | |
| Canon Medical Systems USA, INC. | $67.50 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $52.18 | 2019-2021 | |
| Hologic Sales and Service, LLC | $50.46 | 2022-2024 | Myosure Tissue Removal Device |
| Heartflow, INC. | $50.25 | 2023-2024 | Ffrct |
| Inspire Medical Systems, INC. | $43.44 | 2024-2025 | Inspire |
| Abbott Laboratories | $39.17 | 2019-2021 | |
| Lantheus Medical Imaging, INC. | $29.07 | 2019 | |
| Novo Nordisk INC | $23.44 | 2019 | |
| Sanofi Pasteur INC. | $15.34 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $13.89 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Bingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.